Objective:To identify the influencing factors of postoperative nausea and vomiting (PONV) in the patients undergoing egg retrieval with general anesthesia for in vitro fertilization-embryo transfer (IVF-ET).Methods:This was a case-control study. Medical records from IVF-ET patients undergoing egg retrieval with general anesthesia in the Center for Reproductive Medicine in our hospital from November to December 2020 were retrospectively collected, 52 patients with PONV were identified (group PONV), and 252 patients without PONV were selected as control group (group C). Univariate analysis was performed on the suspicious influencing factors, and the factors with statistically significant differences were included in the logistic regression analysis model to identify the influencing factors of PONV.Results:Compared with group C, statistically significant differences were found in the number of eggs, anesthesia time, and the proportion of PONV history and/or motion sickness history in group PONV ( P<0.05). The results of multivariate logistic regression analysis showed that a large number of eggs, long anesthesia time, and a high proportion of PONV history and/or motion sickness history were independent risk factors for PONV. Conclusions:A large number of eggs, long anesthesia time, and a high proportion of PONV history and/or motion sickness history are independent risk factors for PONV in IVF-ET patients undergoing egg retrieval with general anesthesia.

With the deepening of the research on uric acid, it has been found that abnormal uric acid metabolism is not only related to kidney and cardiovascular diseases, but also closely related to reproductive system diseases such as polycystic ovary syndrome (PCOS). Uric acid can play an important role in the occurrence and development of PCOS through oxidative stress, chronic inflammation and interference with key enzyme activities. PCOS is primarily characterized by hyperandrogenemia, insulin resistance, and dysregulation of glucose and lipid metabolism. Researches have found that there is an interaction between hyperuricemia and hyperandrogenemia, as well as abnormal glucose and lipid metabolism. Additionally, elevated serum uric acid levels are associated with a higher incidence of pregnancy complications and adverse pregnancy outcomes in women with PCOS. However, there are few reviews on this aspect. Therefore, this review aims to provide a more comprehensive scientific basis for the clinical treatment and management of PCOS by deeply exploring the relationship between uric acid metabolism and the main clinical manifestations of PCOS, as well as the impact of abnormal uric acid metabolism on pregnancy outcomes and complications in PCOS patients.

With the deepening of the research on uric acid, it has been found that abnormal uric acid metabolism is not only related to kidney and cardiovascular diseases, but also closely related to reproductive system diseases such as polycystic ovary syndrome (PCOS). Uric acid can play an important role in the occurrence and development of PCOS through oxidative stress, chronic inflammation and interference with key enzyme activities. PCOS is primarily characterized by hyperandrogenemia, insulin resistance, and dysregulation of glucose and lipid metabolism. Researches have found that there is an interaction between hyperuricemia and hyperandrogenemia, as well as abnormal glucose and lipid metabolism. Additionally, elevated serum uric acid levels are associated with a higher incidence of pregnancy complications and adverse pregnancy outcomes in women with PCOS. However, there are few reviews on this aspect. Therefore, this review aims to provide a more comprehensive scientific basis for the clinical treatment and management of PCOS by deeply exploring the relationship between uric acid metabolism and the main clinical manifestations of PCOS, as well as the impact of abnormal uric acid metabolism on pregnancy outcomes and complications in PCOS patients.

Objective To evaluate the significance of tumor markers CEA and CA15-3,and biochemical markers of bone turnover (total procol]agen type Ⅰ amino-terminal propeptide (TP I NP),β-isomerized carboxyterminal propeptide (β-CTx),ALP and PTH) in the diagnosis of bone metastasis from breast cancer.Methods A total of 78 patients (all females) with mean age (56.72 ± 10.76) years,who were diagnosed with breast cancer,were included in this study.The patients were divided into two groups based on radionuclide bone imaging:with bone metastasis (n =32) and without bone metastasis (n =46).The serum concentrations of CEA,CA15-3,TP I NP,[β-CTx,PTH,ALP were measured.Gleason scores were evaluated.The diagnostic value was evaluated by ROC curve.The two groups were compared using two-sample t test.The correlations between bone metastasis and tumor markers,bone metastasis and biochemical markers of bone turnover were analyzed with Pearson correlation and logistic analysis.Results The serum levels of CEA,CA15-3,TPINP,β-CTx,PTH and ALP were significantly higher in the group with bone metastasis than those in the group without bone metastasis (t:4.16-7.56,all P ＜ 0.05).For the diagnosis of bone metastasis from breast cancer,the AUC of CEA,CA15-3,TPINP,[β-CTx,PTH and ALP was 0.815,0.887,0.869,0.852,0.844,0.731,respectively.Using the cut-off values of 4.18 μg/L for CEA,0.04 U/L for CA15-3,49.70 μg/L for TP I NP,0.47 pg/L for β-CTx,54.90 ng/L for PTH and 49.90 U/L for ALP,the sensitivities were 56.3％ (18/32),75.0％ (24/32),78.1％ (25/32),81.3％ (26/32),78.1％ (25/32),68.8％ (22/32) and the specificities were 80.4％ (37/46),84.8％ (39/46),76.1％ (35/46),78.3％ (36/46),69.6％ (32/46),58.7％ (27/46),respectively.CEA,CA15-3,TPINP,β-CTx,PTH,ALP and Gleason score were positively correlated with the presence of bone metastasis (r:0.267-0.636,all P ＜ 0.05).CEA,CA15-3,TP I NP,β-CTx,PTH and Gleason score were independent predictors for bone metastasis of breast cancer (odds ratios:2.45,3.44,1.24,1.54,1.11,2.22,all P ＜0.05).The total coincidence rate of regression model was 81.3％ (26/32) in patients with bone metastasis.Conclusions The diagnostic values of CEA,CA15-3,TP I NP,β-CTx and PTH are comparable.Combined use of these parameters may be helpful for the early diagnosis of bone metastasis from breast cancer.